Walgreens Boots Alliance (WBA)
(Real Time Quote from BATS)
$8.77 USD
+0.03 (0.34%)
Updated Sep 6, 2024 03:55 PM ET
After-Market: $8.74 -0.03 (-0.34%) 4:12 PM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.77 USD
+0.03 (0.34%)
Updated Sep 6, 2024 03:55 PM ET
After-Market: $8.74 -0.03 (-0.34%) 4:12 PM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum D VGM
Zacks News
Zacks Industry Outlook Highlights CVS Health, Walgreens Boots Alliance and Amazon
by Zacks Equity Research
CVS Health, Walgreens Boots Alliance and Amazon have been highlighted in this Industry Outlook article.
2 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Challenges
by Urmimala Biswas
The Zacks Retail Pharmacy and Drugstore industry is gaining from the growing demand for digital healthcare support. Industry players like CVS and WBA are likely to gain the most. However, reimbursement challenges are hurting the overall industry health.
Is Trending Stock Walgreens Boots Alliance, Inc. (WBA) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Walgreens (WBA). This makes it worthwhile to examine what the stock has in store.
Here's Why You Should Retain Walgreens Boots (WBA) For Now
by Zacks Equity Research
Investors are optimistic about Walgreens Boots (WBA), given its better-than-expected earnings and strategic alliances.
Is Most-Watched Stock Walgreens Boots Alliance, Inc. (WBA) Worth Betting on Now?
by Zacks Equity Research
Zacks.com users have recently been watching Walgreens (WBA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Company News for Jul 1, 2022
by Zacks Equity Research
Companies in The News Are: WBA,LNN,NG,RH
Worst 1H Since 1970 Ends Trading Day in the Red
by Mark Vickery
It's been the worst first half of a year for equity markets in more than half a century. So why should the final trading day of it be anything but down?
Walgreens Boots (WBA) Q3 Earnings Top Estimates, Revenues Miss
by Zacks Equity Research
Walgreens Boots (WBA) reports better-than-expected Q3 earnings, with robust sales contributions from the International and Walgreens Health segments.
Walgreens Boots Alliance (WBA) Beats Q3 Earnings Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 1.05% and 0.43%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?
Company News for Jun 28, 2022
by Zacks Equity Research
Companies in The News Are: BNTX,PFE,WBA,HOOD,SAVE,ULCC,JBLU
Walgreens (WBA) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Robust performances across the U.S. pharmacy and retail business are likely to have contributed to Walgreens' (WBA) Q3 performance.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $40.89 in the latest trading session, marking a +1.09% move from the prior day.
Analysts Estimate Walgreens Boots Alliance (WBA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rite Aid (RAD) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Rite Aid (RAD) delivered earnings and revenue surprises of 14.29% and 5%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?
Walgreens (WBA) to Offer Health Services to Ohio Medicaid Members
by Zacks Equity Research
Walgreens' (WBA) subsidiary teams up with Buckeye Health Plan to provide wellness services through Walgreens Health Corner locations in Ohio.
Walgreens (WBA) Starts COVID Jabs for 3-Year Olds & Above
by Zacks Equity Research
Walgreens Boots (WBA) continues to serve communities with COVID testing and vaccinations to fight the pandemic.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $39.32, moving -0.88% from the previous trading session.
Kroger (KR) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Kroger (KR) delivered earnings and revenue surprises of 13.28% and 0.84%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots Alliance (WBA) Stock Moves -0.2%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $40.20, moving -0.2% from the previous trading session.
Amazon (AMZN) Plans to Debut Drone Delivery Service This Year
by Zacks Equity Research
Amazon (AMZN) gears up to offer drone delivery service later this year, for which it has picked Lockeford, CA, as the first location.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $43.39, marking a +0.58% move from the previous day.
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $43.83 in the latest trading session, marking a +0.27% move from the prior day.
Walgreens Boots (WBA) Omnichannel Aids Growth Amid Cost Woes
by Zacks Equity Research
The continued acceleration of Walgreens' (WBA) omnichannel offerings and a significant rise in MyWalgreens membership are notable upsides in recent times.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $42.46, marking a +0.9% move from the previous day.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $40.61, marking a -1.36% move from the previous day.